Table 2 Tumor characteristics between complication and control groups.

From: Analysis of postoperative complications and long term survival following radical gastrectomy for patients with gastric cancer

 

Complication group

(n = 301), n (%)

Control group

(n = 2207), n (%)

Statistic

P value

Location

  

3.536

0.316

Upper

90 (29.9)

648 (29.4)

  

Middle

30 (10.0)

156 (7.1)

  

Lower

166 (55.1)

1283 (58.1)

  

Multiple parts

15 (5.0)

120 (5.4)

  

Number of tumors

  

0.005

0.945

Single

291 (96.7)

2132 (96.6)

  

Multiple (≥ 2)

10 (3.3)

75 (3.4)

  

Histological types

  

0.251

0.882

Differentiated

64 (21.3)

480 (21.7)

  

Mixed

89 (29.6)

622 (28.2)

  

Undifferentiated

148 (49.2)

1105 (50.1)

  

T stage

  

0.964

0.810

T1

71 (23.6)

574 (26.0)

  

T2

48 (15.9)

357 (16.2)

  

T3

77 (25.6)

531 (24.1)

  

T4

105 (34.9)

745 (33.8)

  

N stage

  

2.999

0.392

N0

128 (42.5)

1021 (46.3)

  

N1

43 (14.3)

346 (15.7)

  

N2

56 (18.6)

371 (16.8)

  

N3

74 (24.6)

469 (21.3)

  

Ulceration

  

1.537

0.215

Absence

54 (17.9)

464 (21.0)

  

Presence

247 (82.1)

1743 (79.0)

  

NED

  

0.041

0.839

Absence

287 (95.3)

2110 (95.6)

  

Presence

14 (4.7)

97 (4.4)

  

LVI

  

1.119

0.290

Absence

226 (75.1)

1717 (77.8)

  

Presence

75 (24.9)

490 (22.2)

  

Nerve invasion

  

0.230

0.632

Absence

244 (81.1)

1814 (82.2)

  

Presence

57 (18.9)

393 (17.8)

  
  1. NED, neuroendocrine differentiation; LVI, lymphovascular invasion.